Forza Innovations

Forza Innovations EBITDA Margin

The EBITDA Margin of Forza Innovations (FORZ) as of Oct 31, 2026 is -808.63 %. In the previous year, EBITDA Margin was -808.63 % — a change of 0.00% (lower).

EBITDA Margin

-808.63 %

YoY

0.00%

Last updated:

EBITDA Margin of Forza Innovations is 2024 -808.63 % . EBITDA Margin of Forza Innovations was 2023 -808.63 % . It decreases by 0.00% lower compared to the previous year.

The Forza Innovations EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2017
-3,494.03 USD
Jan 1, 2018
-28.88 USD
Jan 1, 2019
21.13 USD
Jan 1, 2020
-4.07 USD
Jan 1, 2021
-9.94 USD
Jan 1, 2022
-7,342.85 USD
Jan 1, 2023
-808.63 USD
Jan 1, 2024
-808.63 USD
The Forza Innovations EBITDA Margin history
YEAREBITDA MarginYoY
-808.63 %0.00%
-808.63 %-88.99%
-7,342.85 %+73,790.21%
-9.94 %+143.88%
-4.07 %-119.29%
21.13 %-173.16%
-28.88 %-99.17%
-3,494.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Forza Innovations Stock analysis

What does Forza Innovations do? Forza Innovations, Inc. generates revenue through the sale of its WarmUp product line, which includes the J4 Sport, J4 X, and J4 Fitbelt wearable back compression devices. These devices utilize carbon microfibers and rechargeable lithium batteries to provide therapeutic heat application, targeting stiff and sore muscles. The J4 Sport is designed for patients with chronic conditions like arthritis, osteoporosis, fibromyalgia, and ligament strains, while the J4 Fitbelt focuses on abdominal and lower back muscles or single muscle groups. The J4 Core supports users during physical activities, recovery, and daily routines. The company's revenue streams are derived from direct sales of these therapeutic wearable devices to consumers seeking relief from muscle stiffness and inflammation. The WarmUp series targets health-conscious individuals and patients managing chronic pain conditions, positioning itself as a solution for both active lifestyles and medical needs. Products are sold under the WarmUp brand, with specific models catering to distinct user segments based on their therapeutic requirements. Forza Innovations has acquired ownership of late developmental stage products, including the WarmUp line, which are now its primary revenue-generating assets. The company focuses on the health-tech wearable performance market, emphasizing the therapeutic benefits of heat application through its carbon microfiber technology. Sales are driven by the specific medical and wellness applications of each product model. Forza Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Forza Innovations stock

EBITDA Margin of Forza Innovations is -808.63 % in 2024.

EBITDA Margin of Forza Innovations changed from -808.63 % to -808.63 %, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Forza Innovations since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Forza Innovations with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Forza Innovations

All Key Metrics — Forza Innovations